glp-1 microdosing cost costs rise, but there are ways to save on weight-loss drugs Microdosing Ozempic: Benefits, risks and

However, when it comes to weight loss, semaglutide GLP-1 is often marketed under different brand names such as Wegovy, specifically designed for weight management

[2] Not to mention the potential unwanted side effects like nausea, constipation, bloating, and a concerningly low appetite make it hard to stick it out long-term

Beyond 12 months Clinical trials for both Mounjaro and Wegovy show continued weight loss beyond 12 months at therapeutic doses, with average total weight loss of 20 to 22% for tirzepatide 15mg and 14 to 15% for semaglutide 2.4mg at the end of 72-week and 68-week trials respectively

Mol Cell Endocrinol (2009) 297:13740

By 2020, this had decreased to around 292,000